These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 28774279)
1. Pretreatment glycemic control status is an independent prognostic factor for cervical cancer patients receiving neoadjuvant chemotherapy for locally advanced disease. Li J; Ning NY; Rao QX; Chen R; Wang LJ; Lin ZQ BMC Cancer; 2017 Aug; 17(1):517. PubMed ID: 28774279 [TBL] [Abstract][Full Text] [Related]
2. Impact of Poor Preoperative Glycemic Control on Outcomes among Patients with Cervical Cancer Undergoing a Radical Hysterectomy. Liang SH; Shen YC; Wu JY; Wang LJ; Wu MF; Li J Oncol Res Treat; 2020; 43(1-2):10-18. PubMed ID: 31747660 [TBL] [Abstract][Full Text] [Related]
3. Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer. Li J; Wu MF; Lu HW; Chen Q; Lin ZQ; Wang LJ Cancer Med; 2016 Aug; 5(8):1863-72. PubMed ID: 27350066 [TBL] [Abstract][Full Text] [Related]
4. The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy. Wu MF; Guan MM; Liu CH; Wu JY; Rao QX; Li J Cancer Med; 2019 Sep; 8(11):5068-5078. PubMed ID: 31310455 [TBL] [Abstract][Full Text] [Related]
5. Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer. Li J; Wu MF; Lu HW; Zhang BZ; Wang LJ; Lin ZQ PLoS One; 2016; 11(11):e0166612. PubMed ID: 27851819 [TBL] [Abstract][Full Text] [Related]
6. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy]. Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270 [No Abstract] [Full Text] [Related]
7. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer. Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Impact of Neoadjuvant Chemotherapy in Localized or Locoregionally Advanced Gallbladder Cancer: A Population-Based and Propensity Score Matched SEER Analysis. Xiong YC; Yang ZY; Gong A; Wu ZY; Liu SL; Zhu YD; Song XL; Chu BF; Wu XS; Gong W Cancer Control; 2024; 31():10732748241271682. PubMed ID: 39105433 [TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Neoadjuvant Chemotherapy Followed by Radical Surgery Versus Radical Surgery Alone in Locally Advanced Cervical Cancer Patients. Gong L; Zhang JW; Yin RT; Wang P; Liu H; Zheng Y; Lou JY; Peng ZL Int J Gynecol Cancer; 2016 May; 26(4):722-8. PubMed ID: 26905330 [TBL] [Abstract][Full Text] [Related]
10. Are biomarkers expression and clinical-pathological factors predictive markers of the efficacy of neoadjuvant chemotherapy for locally advanced cervical cancer? Ditto A; Longo M; Chiarello G; Mariani L; Paolini B; Leone Roberti Maggiore U; Martinelli F; Bogani G; Raspagliesi F Eur J Surg Oncol; 2024 Jun; 50(6):108311. PubMed ID: 38554552 [TBL] [Abstract][Full Text] [Related]
11. Pretreatment platelet and hemoglobin levels are neither predictive nor prognostic variables for patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy and radical hysterectomy: a retrospective Italian study. Gadducci A; Cosio S; Zola P; Tisi G; Ferrero A; Piovano E; Cristofani R; Greco C; Sartori E Int J Gynecol Cancer; 2010 Nov; 20(8):1399-404. PubMed ID: 21051984 [TBL] [Abstract][Full Text] [Related]
12. Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Cancer: Validity of Pathological Response as Surrogate Endpoint of Survival. Buda A; Lissoni AA; Floriani I; Biagioli E; Gerardi C; Bonazzi C; Chiari S; Locatelli L; Dell'Anna T; Signorelli M; Mangioni C; Milani R Int J Gynecol Cancer; 2015 Oct; 25(8):1468-75. PubMed ID: 26222484 [TBL] [Abstract][Full Text] [Related]
13. The toxicity and long-term efficacy of nedaplatin and paclitaxel treatment as neoadjuvant chemotherapy for locally advanced cervical cancer. Yin M; Zhang H; Li H; Li X; Liu Y; Chen X; Lou G; Li K J Surg Oncol; 2012 Feb; 105(2):206-11. PubMed ID: 21815150 [TBL] [Abstract][Full Text] [Related]
14. How often parametrial involvement leads to post-operative adjuvant treatment in locally advanced cervical cancer after neoadjuvant chemotherapy and type C radical hysterectomy? Martinelli F; Bogani G; Ditto A; Carcangiu M; Papadia A; Lecce F; Chiappa V; Lorusso D; Raspagliesi F Eur J Surg Oncol; 2015 Aug; 41(8):1089-96. PubMed ID: 25890492 [TBL] [Abstract][Full Text] [Related]
15. Adjuvant Chemotherapy in Addition to Neoadjuvant Chemotherapy for Locally Advanced Non-small Cell Lung Cancer. Miyata R; Aoki M; Morizono S; Umehara T; Harada-Takeda A; Kamimura GO; Nagata T; Ueda K In Vivo; 2024; 38(5):2515-2522. PubMed ID: 39187348 [TBL] [Abstract][Full Text] [Related]
16. Robotic Surgery in Patients With Locally Advanced Cervical Cancer After Neoadjuvant Chemotherapy: Survival Outcomes. Siesto G; Romano F; Accardi A; Bulletti C; Iedà NP; Vitobello D Int J Gynecol Cancer; 2016 Mar; 26(3):521-7. PubMed ID: 26825842 [TBL] [Abstract][Full Text] [Related]
17. Decreasing expression of HIF-1α, VEGF-A, and Ki67 with efficacy of neoadjuvant therapy in locally advanced cervical cancer. Zhao K; Hu M; Yang R; Liu J; Zeng P; Zhao T Medicine (Baltimore); 2023 May; 102(20):e33820. PubMed ID: 37335690 [TBL] [Abstract][Full Text] [Related]
18. Optimal pathological response indicated better long-term outcome among patients with stage IB2 to IIB cervical cancer submitted to neoadjuvant chemotherapy. Huang K; Sun H; Chen Z; Li X; Wang S; Zhao X; Tang F; Jia Y; Hu T; Du X; Wang H; Lu Z; Huang J; Gui J; Wang X; Zhou S; Wang L; Zhang J; Guo L; Yang R; Shen J; Zhang Q; Li S; Wang S Sci Rep; 2016 Jun; 6():28278. PubMed ID: 27325186 [TBL] [Abstract][Full Text] [Related]
19. 15-PGDH expression as a predictive factor response to neoadjuvant chemotherapy in advanced gastric cancer. Hu M; Li K; Maskey N; Xu Z; Peng C; Tian S; Li Y; Yang G Int J Clin Exp Pathol; 2015; 8(6):6910-8. PubMed ID: 26261578 [TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy followed by radical surgery reduces radiation therapy in patients with stage IB2 to IIA2 cervical cancer. Huang Y; Chen L; Cai J; Yang L; Sun S; Zhao J; Xiong Z; Wang Z World J Surg Oncol; 2022 Aug; 20(1):264. PubMed ID: 35996118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]